This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "20180119 PLA call"

From HL7Wiki
Jump to navigation Jump to search
(Created page with "{{subst:: PLA Template}}")
 
 
(2 intermediate revisions by the same user not shown)
Line 13: Line 13:
 
| colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 PLA Call Minutes''' <br/>
 
| colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 PLA Call Minutes''' <br/>
 
'''Location: ''' Phone: +1 770-657-9270, Participant Code: 985371, <br/>https://global.gotomeeting.com/join/177894709  
 
'''Location: ''' Phone: +1 770-657-9270, Participant Code: 985371, <br/>https://global.gotomeeting.com/join/177894709  
| colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2017-mm-dd'''<br/> '''Time: 11:30 AM'''
+
| colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2018-01-19'''<br/> '''Time: 11:30 AM'''
 
|-
 
|-
 
| colspan="1" align="right"|'''Facilitator'''
 
| colspan="1" align="right"|'''Facilitator'''
Line 40: Line 40:
 
| || Calvin Beebe
 
| || Calvin Beebe
 
|-
 
|-
| ||Lorraine Constable
+
| x||Lorraine Constable
 
|-
 
|-
 
| || Jean Duteau,
 
| || Jean Duteau,
Line 46: Line 46:
 
| || Tony Julian  
 
| || Tony Julian  
 
|-
 
|-
| || Paul Knapp
+
|x || Paul Knapp
 
|-
 
|-
| || Austin Kreisler,
+
| x|| Austin Kreisler,
 
|-
 
|-
| || Mary Kay McDaniel
+
|x || Mary Kay McDaniel
 
|-
 
|-
 
| || Brian Pech
 
| || Brian Pech
Line 56: Line 56:
 
| || Wayne Kubick
 
| || Wayne Kubick
 
|-
 
|-
| || John Roberts
+
|x || John Roberts
 
|-
 
|-
 
| || Andy Stechishin
 
| || Andy Stechishin
Line 77: Line 77:
 
===Agenda===
 
===Agenda===
 
Agenda review
 
Agenda review
*Notes of [[2017MMDD_PLA_call]] review
+
*Notes of [[20170105_PLA_call]] review
 +
*Action items
 +
**Add to PLA and CIMI PPTs for morning meetings
 +
*Discussion
 +
**Operational policy for introducing new product families - from TSC
 +
**How to manage relationships external to HL7
 
*notional division of products into product families and lines, to provide examples for peer review.
 
*notional division of products into product families and lines, to provide examples for peer review.
 
**Level of granularity
 
**Level of granularity
Line 87: Line 92:
  
 
===Minutes===
 
===Minutes===
Convened
+
Agenda review
 +
*Notes of [[20170105_PLA_call]] review
 +
*Action items
 +
**Add to PLA and CIMI PPTs for morning meetings
 +
***Reviewed MK's slides. She will remind Richard re: CIMI slides.
 +
*Discussion
 +
**2.x meeting on Monday Q3: Austin drafting message and including Mary Kay's and Lorraine's comments. Made changes; Austin will send out this afternoon. Discussion over role of steering divisions vs. management groups. Worked on slides for the V2 meeting.
 +
**Operational policy for introducing new product families - from TSC
 +
***Came out of RDAM issue.
  
Adjourned
 
  
 
===Meeting Outcomes===
 
===Meeting Outcomes===
Line 119: Line 131:
  
 
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/>
 
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/>
*[[2017mmdd PLA call]]
+
*[[TBD]]
  
 
|}
 
|}
  
© 2017 Health Level Seven® International.  All rights reserved
+
© 2018 Health Level Seven® International.  All rights reserved

Latest revision as of 21:58, 25 January 2018

return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program

HL7 PLA Call Minutes

Location: Phone: +1 770-657-9270, Participant Code: 985371,
https://global.gotomeeting.com/join/177894709

Date: 2018-01-19
Time: 11:30 AM
Facilitator Mary Kay/ Austin Note taker(s) Anne
Attendee Name


Calvin Beebe
x Lorraine Constable
Jean Duteau,
Tony Julian
x Paul Knapp
x Austin Kreisler,
x Mary Kay McDaniel
Brian Pech
Wayne Kubick
x John Roberts
Andy Stechishin
no quorum definition

Agenda

Agenda review

  • Notes of 20170105_PLA_call review
  • Action items
    • Add to PLA and CIMI PPTs for morning meetings
  • Discussion
    • Operational policy for introducing new product families - from TSC
    • How to manage relationships external to HL7
  • notional division of products into product families and lines, to provide examples for peer review.
    • Level of granularity
    • Identify which pieces are orphaned, and the political elements to be surfaced.
    • Positioning cross-product family artifacts (standards naming)
  • BAM-lite feedback and review
    • Governance on V2.x (v2.9 substantive changes)
    • develop form to request establishing a Product Family

Minutes

Agenda review

  • Notes of 20170105_PLA_call review
  • Action items
    • Add to PLA and CIMI PPTs for morning meetings
      • Reviewed MK's slides. She will remind Richard re: CIMI slides.
  • Discussion
    • 2.x meeting on Monday Q3: Austin drafting message and including Mary Kay's and Lorraine's comments. Made changes; Austin will send out this afternoon. Discussion over role of steering divisions vs. management groups. Worked on slides for the V2 meeting.
    • Operational policy for introducing new product families - from TSC
      • Came out of RDAM issue.


Meeting Outcomes

Actions
Next Meeting/Preliminary Agenda Items

© 2018 Health Level Seven® International. All rights reserved